Skip to content
WeighLab
Menu
Ranked #83 · Grade C

Rivo Health review

Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members claimed, Trustpilot 4.7) whose advertised $149/mo semaglutide and $199/mo tirzepatide are the 12-month annual-plan rate, not month-to-month.

Visit Rivo Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$149/mo (starting dose, annual plan, compounded oral)
Tirzepatide
$199/mo (starting dose, annual plan, compounded oral)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,788

Tirzepatide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Rivo Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month62/100
Price Transparency78/100
Nationwide Access86/100
Formulation Options77/100
Clinical Oversight79/100
Contract Flexibility33/100

Where the value is

  • Bundles a membership (unlimited provider visits, dietitian, coaching) into the plan at no separately-billed cost
  • Large, established program with a stated 115,000+ member base and 4.7 Trustpilot rating
  • Both injectable and oral compounded options for semaglutide and tirzepatide
  • 'If you don't qualify, you don't pay' risk-free framing on the initial assessment

The tradeoffs

  • The headline $149/$199 prices require a 12-month annual-plan commitment — the genuine month-to-month rate, shown crossed out on the same page, is $279/mo and $389/mo, 87-95% higher
  • Compounding pharmacy partner is not named anywhere reachable
  • No LegitScript certification found on the pages reviewed
  • States served were not listed on the pages reached in this research

The bottom line

Best for: Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in. Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members claimed, Trustpilot 4.7) whose advertised $149/mo semaglutide and $199/mo tirzepatide are the 12-month annual-plan rate, not month-to-month.

Ranked #83 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Rivo Health.

The 24 programs nearest this one

Pricing, states and verification reflect Rivo Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Rivo Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard